Minaris Regenerative Medicine, LLC
FDA inspection history in Allendale, New Jersey, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Allendale, New Jersey.
Cited most
Across all Minaris Regenerative Medicine observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
The complete Minaris Regenerative Medicine file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Allendale, New Jersey
One Form 483 · 2023 · 1 observation
Latest: Form 483, Sep 25, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-09-25 | 483 Form 483 | Allendale, New Jersey | 1 | $99 |
Investigators on these documents
Alan Baer (1)Christine Harman (1)Graeme Price (1)Phillip Thai (1)
FEI number 3003407523 · most recent document Sep 25, 2023
About Minaris Regenerative Medicine, LLC
How many FDA Form 483s has Minaris Regenerative Medicine, LLC received?
FDA Intel has 1 Form 483 on file for Minaris Regenerative Medicine, LLC; the most recent is dated Sep 25, 2023.
When was Minaris Regenerative Medicine, LLC last inspected by FDA?
The most recent FDA inspection document on file for Minaris Regenerative Medicine, LLC is a Form 483 dated Sep 25, 2023, for the site in Allendale, New Jersey.
What did FDA cite at Minaris Regenerative Medicine, LLC?
The regulations cited most in the observations on file for Minaris Regenerative Medicine, LLC are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time.